Product Images Levetiracetam

This text provides instructions for calculating the total daily dose in milliliters (mL) based on the patient's weight and the daily dose prescribed in milligrams per kilogram (mg/kg). The calculation involves multiplying the daily dose by the patient's weight in kg. The text mentions that the concentration of the medication is 100 mg/mL.*

This appears to be a formula for calculating creatinine clearance in adults based on age, weight, and serum creatinine levels. However, it is missing some additional information such as the units of the final result.*

The text is a chart showing the percentage of patients in different treatment groups. The treatments are placebo, Levetiracetam at 1000 mg/day and Levetiracetam at 3000 mg/day. The chart shows that the percentages range from 0% to 39.6% with the highest percentage being for the 3000 mg/day group.*

This appears to be a chart showing the percentage of patients and the effectiveness of three treatments (placebo, 1000mg/day Levetiracetam, and 2000mg/day Levetiracetam) based on a sample size of 106 patients. The percentages shown represent how many patients saw improvement while on each treatment.*

The text shows a chart displaying percentages of patients in increments of 5 from 45% down to 0%. The chart also indicates two treatment options, Placebo and Levetiracetam 3000 mg/day, and the number of patients in each group (N=109 for Placebo and N=180 for Levetiracetam). The percentage of patients who experienced a certain outcome has been left blank, except for 39.4% for an unknown treatment. It is not possible to determine what outcome was being measured based on the given information.*

This appears to be a chart showing the percentage of patients with a certain drug (Levetiracetam) compared to a placebo, with different percentages ranging from 0% to 45%. The number of patients in each group is also specified (N=97 for the placebo group, and N=101 for the Levetiracetam group).*

This appears to be a table or chart displaying the percentage of patients in a study who received either a placebo or the medication Levetiracetam. The percentages shown are 45.2% for the placebo group and 72.2% for the Levetiracetam group. The sample sizes for each group (N=84 for placebo and N=79 for Levetiracetam) are also provided.*

This is a label from a medication bottle for an oral solution of Levitiracetam. The dosage is 100mg/mL and the medication guide should be given to each patient. The usual dosage information is not available on the bottle, so a pharmacist should check the package insert. The solution should be stored in a light-resistant container at 20°-25°C and kept out of reach of children. The label includes a prescription-only warning and the drug should be dispensed by a pharmacist. The manufacturer is Oakorn and their address is listed in Lake Forest, IL. The label was last revised in October 2020.*